Literature DB >> 25015854

Large B-cell lymphomas poor in B cells and rich in PD-1+ T cells can mimic T-cell lymphomas.

Robert S Ohgami1, Shuchun Zhao2, Yasodha Natkunam2.   

Abstract

OBJECTIVES: To characterize the clinicopathologic features of cases of large B-cell lymphomas, poor in B cells and densely rich in programmed cell death-1 (PD-1)+ reactive T cells, which can mimic T-cell lymphomas.
METHODS: A single-institute retrospective review of cases between 2010 and 2013 was performed.
RESULTS: Of 178 cases of large B-cell lymphomas, eight cases of large B-cell lymphomas poor in B cells and diffusely rich in sheets of PD-1+ T cells were identified. These cases either were initially misdiagnosed as a T-cell lymphoma or substantiated a broader differential diagnosis including a T-cell lymphoma. Five cases were T-cell histiocyte-rich large B-cell lymphomas, and three cases were diagnosed as large B-cell lymphomas rich in T cells. In three of these cases, a subset of the PD-1+ T cells showed either morphologic nuclear atypia or atypical expression of T-cell antigens on flow cytometry and/or immunohistochemistry.
CONCLUSIONS: Large B-cell lymphomas poor in B cells and rich in T cells can have diffuse sheets of reactive PD-1+ T cells, some with atypical morphologic and immunophenotypic features mimicking a T-cell lymphoma. Careful assessment of the immunoarchitecture and background inflammatory and stromal cells can prevent erroneous diagnoses in such cases. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Large B-cell lymphoma; PD-1+ T cells; T-cell histiocyte rich large B-cell lymphoma

Mesh:

Substances:

Year:  2014        PMID: 25015854     DOI: 10.1309/AJCPFJWKQ6GTVQE6

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.

Authors:  Jingxuan Wang; Kun Gao; Wanting Lei; Lina Dong; Qijia Xuan; Meiyan Feng; Jinlu Wang; Xiangnan Ye; Tuan Jin; Zhongbai Zhang; Qingyuan Zhang
Journal:  Oncotarget       Date:  2017-01-17

2.  Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.

Authors:  Keith E Steele; Tze Heng Tan; René Korn; Karma Dacosta; Charles Brown; Michael Kuziora; Johannes Zimmermann; Brian Laffin; Moritz Widmaier; Lorenz Rognoni; Ruben Cardenes; Katrin Schneider; Anmarie Boutrin; Philip Martin; Jiping Zha; Tobias Wiestler
Journal:  J Immunother Cancer       Date:  2018-03-06       Impact factor: 13.751

3.  T-cell/histiocyte-rich large B-cell lymphoma in a child: A case report and review of literature.

Authors:  Chapman Wei; Chaplin Wei; Omar Alhalabi; Lei Chen
Journal:  World J Clin Cases       Date:  2018-06-16       Impact factor: 1.337

Review 4.  Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.

Authors:  Lin Shui; Xi Yang; Jian Li; Cheng Yi; Qin Sun; Hong Zhu
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.